All treatments
Treatment
Nirmatrelvir/ritonavir clinical trials
2 indexed studies · 2 currently recruiting
- RecruitingPHASE3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
This study, called REMAP-CAP, looks at different treatments for serious lung infections like pneumonia, flu, and COVID-19 in adults needing intensive care. It aims to find out which treatments work best to help patients recover.
For: Community-acquired Pneumonia, Influenza, COVID-19United States · Australia · Belgium - RecruitingPHASE4
Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial
This study, called DEFEND, is looking at whether existing medicines, Paxlovid or Veklury, can help prevent serious heart and blood vessel problems in hospitalised adults who have had COVID-19. It's a first step to see if these treatments can reduce lasting health issues from the virus.
For: SARS CoV-2 Post-Acute SequelaeCanada